Status:
WITHDRAWN
COVID-19 Prevalence and Cognitive Deficits in Neurological Patients
Lead Sponsor:
Aarhus University Hospital
Conditions:
Neurological Diseases or Conditions
Stroke, Acute
Eligibility:
All Genders
18+ years
Brief Summary
The purpose is to investigate the COVID-19 prevalence, associated morbidity and long-term cognitive deficits in consecutive patients presenting with acute neurological symptoms
Detailed Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading in nearly every country in the world. Patients with coronavirus disease 2019 (COVID-19) typically present with cough, fever a...
Eligibility Criteria
Inclusion
- Eligibility criteria for the extended study:
- Adult patients
- New onset of neurological symptoms
- Independent in daily activities (modified Rankin Scale ≤ 2)
- Stroke or epilepsy/seizure
Exclusion
- Pre-existing neurodegenerative disease
- Diagnosed with cerebral neoplasm
- Pre-existing expected life expectancy \< 3 months
- Suspected non-organic (functional) disorder
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04377425
Start Date
May 7 2020
End Date
June 30 2022
Last Update
September 3 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, DK, Denmark, 9000
2
Aarhus University Hospital
Aarhus, DK, Denmark, 8200
3
Regional Hospital West Jutland, Hostebro
Holstebro, DK, Denmark, 7500
4
Regional Hospital Central Jutland, Viborg
Viborg, DK, Denmark, 8800